# Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

> **NCT00350454** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 605 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DEVICE:** rapamycin-eluting Stent with permanent polymer
- **DEVICE:** rapamycin-eluting stent with biodegradable polymer
- **DEVICE:** polymer-free, rapamycin-eluting stent

## Key facts

- **NCT ID:** NCT00350454
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-10
- **Target enrollment:** 605 (ACTUAL)
- **Last updated:** 2008-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00350454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00350454, "Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00350454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*